Guidelines’ recommendations for the treatment-resistant depression: A systematic review of their quality
PLOS ONE · 06.02.2023 · 18 (2) · e0281501
DOI: 10.1371/journal.pone.0281501 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift PLOS ONE, online erschienen am 06.02.2023. Verfasst von Franciele Cordeiro Gabriel und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Farmácia, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, São Paulo, Brasil. Hauptthemen laut MEDLINE: Depression, Electroconvulsive Therapy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Themen: Depression
Abstract (Originalsprache)
Introduction
Depression is a serious and widespread mental health disorder. A significant proportion of patients with depression fail to remit after two antidepressant treatment trials, a condition named treatment-resistant depression (TRD). Clinical practice guidelines (CPGs) are instruments aimed to improve diagnosis and treatment. This study objective is to systematically appraise the quality and elaborate a comparison of high-quality CPGs with high-quality recommendations aimed at TRD. Methods and analysis We searched several specialized databases and organizations that develop CPGs. Independent researchers assessed the quality of the CPGs and their recommendations using AGREE II and AGREE-REX instruments, respectively. We selected only high-quality CPGs that included definition and recommendations for TRD. We investigated their divergencies and convergencies as well as weak and strong points.
Results
Among seven high-quality CPGs with high-quality recommendations only two (Germany’s Nationale Versorgungs Leitlinie–NVL and US Department of Veterans Affairs and Department of Defense–VA/DoD) included specific TRD definition and were selected. We found no convergent therapeutic strategy among these two CPGs. Electroconvulsive therapy is recommended by the NVL but not by the VA/DoD, while repetitive transcranial magnetic stimulation is recommended by the VA/DoD but not by the NVL. While the NVL recommends the use of lithium, and a non-routine use of thyroid or other hormones, psychostimulants, and dopaminergic agents the VA/DoD does not even include these drugs among augmentation strategies. Instead, the VA/DoD recommends ketamine or esketamine as augmentation strategies, while the NVL does not mention these drugs. Other differences between these CPGs include antidepressant combination, psychotherapy as a therapeutic augmentation, and evaluation of the need for hospitalization all of which are only recommended by the NVL.
Conclusions
High-quality CPGs for the treatment of depression diverge regarding the definition and use of the term TRD. There is also no convergent approach to TRD from currently high-quality CPGs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departamento de Farmácia, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, São Paulo, Brasil.
- Departamento de Saúde Coletiva, Universidade Federal de Ciências da Saúde de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brasil.
- Gerência de Ensino e Pesquisa do Grupo Hospitalar Conceição, Porto Alegre, Rio Grande do Sul, Brasil.
- Departamento de Ciências Farmacêuticas, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Diadema, São Paulo, Brasil.
- Faculdade de Saúde Pública, Universidade de São Paulo, São Paulo, São Paulo, Brasil.
- Departamento e Instituto de Psiquiatria, Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo, Divisão de Psiquiatria e Psicologia Hospital, São Paulo, Brasil.
ORCID-Profile: Franciele Cordeiro Gabriel, Daniela de Oliveira Melo, Gessica Caroline Henrique Fontes-Mota, Renério Fráguas, Eliane Ribeiro
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Gabriel, F. C., Stein, A. T., Melo, D. O., Fontes-Mota, G. C. H., Dos Santos, I. B., Rodrigues, C. D. S., Dourado, A., Rodrigues, M. C., Fráguas, R., Florez, I. D., Correia, D. T., & Ribeiro, E. (2023). Guidelines’ recommendations for the treatment-resistant depression: A systematic review of their quality. PLOS ONE, 18(2), e0281501. https://doi.org/10.1371/journal.pone.0281501
Vancouver
Gabriel FC, Stein AT, Melo DO, Fontes-Mota GCH, Dos Santos IB, Rodrigues CDS, et al. Guidelines’ recommendations for the treatment-resistant depression: A systematic review of their quality. PLOS ONE. 2023;18(2):e0281501. doi:10.1371/journal.pone.0281501
BibTeX
@article{Gabriel2023,
author = {Gabriel, Franciele Cordeiro and Stein, Airton Tetelbom and Melo, Daniela de Oliveira and Fontes-Mota, Gessica Caroline Henrique and Dos Santos, Itamires Benício and Rodrigues, Camila da Silva and Dourado, Andrea and Rodrigues, Mônica Cristiane and Fráguas, Renério and Florez, Ivan D and Correia, Diogo Telles and Ribeiro, Eliane},
title = {Guidelines’ recommendations for the treatment-resistant depression: A systematic review of their quality},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {2},
pages = {e0281501},
doi = {10.1371/journal.pone.0281501}
}
EUVIMED